Skip to content

Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures

Clinical Evaluation on HA Coated Dynamic Hip Screws for Trochanteric Femoral Fractures

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05677061
Enrollment
37
Registered
2023-01-10
Start date
2008-04-30
Completion date
2023-02-28
Last updated
2023-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intertrochanteric Fractures

Keywords

Stable Fractures (Evans I, II, IV)

Brief summary

Evaluated whether HA coated dynamic hip screws can improve fixation of the screw in trochanteric femoral fractures

Detailed description

Randomised study to determine the effect of HA coating on the stability of dynamic Hip screws used to stabilize femoral neck fractures. Stability of the screw will be determined by RSA measurements. Additionally the fracture stability will be evaluated by RSA measurements.

Interventions

DEVICEDynamic Hip Screw with HA-coating (Hiploc)

During surgery for pertrochanteric hip fracture a lag screw with hydroxyapatite coating on the screw thread was used to fix the fracture

DEVICEDynamic Hip Screw without coating (Hiploc)

During surgery for pertrochanteric hip fracture a lag screw with no coating on the screw thread was used to fix the fracture

Sponsors

Hospitalsenheden Vest
CollaboratorOTHER
Hvidovre University Hospital
CollaboratorOTHER
University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Intervention model description

Patient and Assessor blinded randomized controlled trial

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with stable intertrochanteric femoral fractures (Evans I, II, IV) * able to speak Danish * able to complete the postoperative controls * written consent

Exclusion criteria

* unable to follow standard hip fracture regime * were breastfeeding * pregnant * terminal disease * in need of open fracture reduction * in need of DHS plate with an angle different from 135 degrees * insertion of fewer than 3 tantalum beads in the femoral head (for RSA) * TAD \>20mm in two dimensions in the first postoperative x-ray * fracture displacement \>20mm in two dimensions in the first postoperative x-ray

Design outcomes

Primary

MeasureTime frameDescription
Lag Screw migration measured as y-translation (mm)6 months POLag screw migration measured as y-translation (mm) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up

Secondary

MeasureTime frameDescription
Lag screw migration measured as rotations in degrees6 months POLag screw migration measured as rotations in degrees about the three orthogonal axes (x, y and z) in addition to the summed summed rotations (total rotation) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up
Radiological measurements6 monthsTAD AP+LAT, fracture reposition AP+LAT (mm)
Clinical outcomes - HHS6 months POChange in Harris Hip Score (HHS) measured as a scale from 0 (worst) to 100 (best) from pre-operative til 6 months postoperative
Lag screw migration measured as translations in mm6 months POLag screw migration measured as translations in mm along the three orthogonal axes (x and z) and rotations in degrees about the three orthogonal axes (x, y and z) in addition to the summed translations (total translation) and summed rotations (total rotation) with respect to the femoral head/neck fracture segment using marker-based radiostereometry (ModelBased RSA vs 4.2 or newer) until 6 months follow-up
Clinical outcomes - Leg Lengths difference6 monthsLeg Length difference in cm at 6 months follow-up indicate fracture impaction
Clinical outcomes - TUG test6 monthsTimed Up and Go Test (TUG) at 6 months follow-up (a score less than 20 seconds indicate mobility independence)
Clinical outcomes - NMSPreoperativeNew Mobility Score measured on a scale from 0 (no mobility function) to 9 (full independent mobility function) preoperative

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026